Share Your Content with Us
on TradePub.com for readers like you. LEARN MORE
Helping to protect eligible adults against pneumococcal disease caused by certain medically important serotypes

Register for Your Free Live Webinar Now:

"Helping to protect eligible adults against pneumococcal disease caused by certain medically important serotypes"

Join us on October 29 at 1:00 PM ET.

In this webinar, attendees will learn more about the FDA-approved vaccine, and how protection against different serotypes of pneumococcal bacteria can help protect eligible patients.

Join a medical expert in a Pfizer-sponsored presentation to learn about the burden of pneumococcal disease in adults, the potential importance of direct protection through vaccination, and the critical role healthcare providers can play in improving pneumococcal vaccination rates in eligible adults.

During this session, attendees will:

  • Understand the burden of pneumococcal disease in adults
  • Recognize the importance of direct protection against serotypes that cause both invasive pneumococcal disease and pneumococcal pneumonia.
  • Hear the recommendations for adult pneumococcal vaccination
  • Embrace the role of healthcare providers in helping improve adult pneumococcal vaccination uptake

Speaker: 

Chad J. Kodiak, RPh, PharmD   

President/CEO                                       

KODOCARE Pharmacy                             

Joliet, Illinois

Dr. Kodiak is being compensated for his time


Offered Free by: Pfizer
See All Resources from: Pfizer

Recommended for Professionals Like You: